Treace Medical Concepts

Treace Medical Presents Positive Clinical Data for 3D Bunion Correction Technologies at ACFAS 2026

- Treace Medical Concepts presented interim data from three clinical studies at the ACFAS 2026 conference, demonstrating positive outcomes for their bunion correction technologies. - The ALIGN3D study showed 8.4% radiographic recurrence rates at 48 months and 95% lower recurrence risk in patients with proper 3D correction. - The company unveiled six new product innovations including SpeedTMT rapid compression implants and Lightning instrumentation system for enhanced surgical precision. - Clinical data demonstrated early weight-bearing recovery averaging 3.7-8.4 days across different procedures with maintained correction through 24 months.